Press releases

30 Jan 2019

Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo

Press releases

29 Jan 2019

MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases

Press releases

23 Jan 2019

Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia

Press releases

17 Jan 2019

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

Press releases

16 Nov 2018

European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness

Press releases

12 Sep 2018

New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier

Press releases

5 Sep 2018

DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil

Press releases

23 Jul 2018

FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment

Press releases

14 Apr 2018

DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients

Press releases

13 Apr 2018

Clinical trial to find new treatment for visceral leishmaniasis begins in eastern Africa

Press releases

13 Apr 2018

Drug approved in Argentina for treatment of Chagas disease in children

Press releases

12 Apr 2018

New affordable hepatitis C combination treatment shows 97% cure rate

Press releases

5 Apr 2018

Takeda Pharmaceutical and DNDi collaborate to progress a potential new drug for visceral leishmaniasis through the R&D pipeline

Press releases

27 Mar 2018

DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease

Press releases

5 Mar 2018

Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America

Press releases

6 Feb 2018

New open source drug discovery project aims to develop mycetoma treatment